Pamela (Pam) Marrone

Harnessing the power of fermentation to create delicious mycoprotein ingredients, The Better Meat Co. empower our customers to make meat thats better for the planet, animals, and public health. We love fungi!

TrueAlgae™ is a US based biotechnology company with global reach. Our revolutionary closed-loop, proprietary algae production technology allows delivery of high quality microalgae for a multitude of uses including agriculture, aquaculture, human and animal nutrition as well as personal care products.

ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, plant development and climate data to quantify the results obtained under real-life conditions.

180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).

Teneral Cellars was founded in Northern California in 2020. We are a women-owned and operated producer of sustainable, phenomenal wines, harnessing the power of business for good. Exceptional wine is our catalyst for connection, crucial conversations, and investments toward an equitable future for all women. Though we are veterans of the industry, we are the first to disrupt it by elevating women into leadership positions and providing education, grants, and employment opportunities, specifically to women of color. We donate 10% of profits to organizations that empower women and promote gender and racial equity.

CHONEX is a soil health company founded to help make agriculture more sustainable by providing the live microbes essential to healthy soil. Using a process built and refined in nature for eons, our product STRONGSOIL converts poultry manure into high-value bio-fertilizer and bio-stimulant that restores degraded soil to health. In so doing, STRONGSOIL is helping to build a more sustainable world.

WERE HIRING! The Arber team is growing! Were looking for the following positions: Senior Designer, Remote Operations & Supply Chain Manager, Remote Community Manager, Remote Biological Plant Wellness Products to Nourish Green Spaces and Empower Home Gardeners. Arber is the first of its kind plant wellness company dedicated to helping both our planet and people thrive. Our premier line of biologicals safely and efficaciously sustain all greenspaces; while our products benefit plants, soil, and Mother Nature - she needs our help! Biologicals are powerful, naturally occurring substances such as bacteria, microbes, and plant extracts that prevent plant diseases, control unwanted pests, and promote unparalleled growth and abundance, all while doing good for us and the earth. Launching Spring 2021

StemExpress was founded in 2010 to accelerate the cure and prevention of significant medical conditions at life-changing speed. StemExpress supports cell and gene therapies, commercialization of disease specific treatments, medical research, clinical trials, precision/regenerative medicine, among other researchers and clinicians around the world who are developing and implementing revolutionary treatments and cures. StemExpress is currently the nation's leading biospecimen provider of human primary cells, stem cells, human bone marrow, cord blood, peripheral blood, maternal blood, and disease-state products for academic, biotechnological, diagnostic, pharmaceutical and contract research organizations. StemExpress is registered with the U.S. Food and Drug Administration (FDA) and has seven (7) independently owned and operated brick-and mortar cellular clinics across the United States to collect blood, cells and tissue from patients and donors. These clinics include state-of-the-art cell manufacturing laboratories for clinical and research purposes, and CLIA certified/high-complexity diagnostics. #celltherapy #genetherapy #primarycells #immunotherapy #immunology #cancerresearch #biotechnology #biospecimens #cancerresearch #biomedicalresearch #stemcellresearch #covidtesting

The Foundation for Food & Agriculture Research (FFAR) builds public-private partnerships to fund bold research addressing big food and agriculture challenges. FFAR was established in the 2014 Farm Bill to increase public agriculture research investments, fill knowledge gaps and complement USDA’s research agenda. FFAR’s model matches federal funding from Congress with private funding, delivering a powerful return on taxpayer investment. Through collaboration and partnerships, FFAR advances actionable science benefiting farmers, consumers and the environment.

The Biological Products Industry Alliance (BPIA) works to improve the global market perceptions of biological products. BPIA accomplishes this purpose by promoting the responsible development of safe and effective biological products as beneficial tools for agriculture, horticulture, public health, and consumers through education, outreach, and advocacy activities.

Harnessing the power of fermentation to create delicious mycoprotein ingredients, The Better Meat Co. empower our customers to make meat thats better for the planet, animals, and public health. We love fungi!

TrueAlgae™ is a US based biotechnology company with global reach. Our revolutionary closed-loop, proprietary algae production technology allows delivery of high quality microalgae for a multitude of uses including agriculture, aquaculture, human and animal nutrition as well as personal care products.

ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, plant development and climate data to quantify the results obtained under real-life conditions.

The ISC was started by experience, successful entrepreneurs dedicated to the discovery, development & deployment of sustainable biological solutions to control invasive species, increase biodiversity and address climate change. Invasive species have caused over $2 trillion in economic and environmental damage and are the second largest cause of biodiversity loss. Invasive species are getting worse with climate change. We are currently selling Zequanox(r) for control of invasive zebra and quagga mussels in pipes and water bodies. We have a collaboration with the USGS to finish development of Piscamycin(r), a natural product to control invasive carp and other invasive fish. We have a microbial and plant natural product screening platform, guided by AI and machine learning for discovery of microbial natural products to control toxic algae and aquatic and terrestrial weeds.

180 Life Sciences Corp. (NASDAQ: ATNF) is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor).